Viewing profile — crispycas12

Seems to be Adler and Jumper moving to Anthropic is some of the impetus to disband, no?

That's odd. This was content that was still on the MCAT when I took it last year. I even remember keeping the formation of objection permanence occuring ~0-2 years of age on my fla…

You're mostly correct but immunotherapies do work for a many different type of cancer. The issue is differences in tumor biology plays a major factor. The even bigger caveat is tha…

I believe he got just got either Ipilimumab and Nivolumab as a combo therapy or Pembrolizumab. He's a researcher who focuses on neo-adjuvant (use therapy before resection) therapy …

It's neo-adjuvant (treat prior to surgery) with a three mAbs: Ipi + Nivo, which is a well established combo of immunotherapeutics for many solid tumors, rounded out with relatlimab…

Ok very quick notes • Prostate cancers are known to have a wide spectrum of outcomes. • Stage IV (metastatic) disease tends to have genetic testing. These panels tend to be on the …

Personally, I think confabulations would be a better term. To the best of my understanding, these AI rely on a model similar to the reconstructive theory of memory in humans. The c…

This theory probably has more transnational value to oncology in the nearer term than anti-aging IMO.

Actual article here: https://www.embopress.org/doi/abs/10.15252/embj.2022111133 Edit: My best read of the article is as follow, please correct me if I am wrong. RB is retinoblastom…

TBH I'm surprised how hard Illumina is already pushing Galleri as a product. Current ctDNA/cfDNA are imperfect for advanced cancers which should have a lot of shedding to begin wit…